NCT06844552 Diamagnetic Therapy in Pain and Inflammation
| NCT ID | NCT06844552 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Catanzaro |
| Condition | Pain |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-02-19 |
| Primary Completion | 2025-07-19 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2025-02-19 with a primary completion date of 2025-07-19.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective longitudinal single-center clinical study on pain patients treated with Low Frequency High Intensity- Pulsed Magnetic Fields (LF-HI-PEMF; diamagnetic therapy) . Patients were enrolled at baseline (T0) and then were monitored at 30 days (T1), 60 days (T2), 90 days (T3). and 360 days (T4). The first efficacy end-point was the statistically significant difference (P\<0.05) in VAS scale between T2-T4 and T0.
Eligibility Criteria
Inclusion Criteria: 1. Patients of both sexes between 18 and 75 years old 2. Patients with pain and or inflammation (e.g. osteoarthritis, trauma, prostatitis) 3. Patients with VAS (Visual Analogue Scale) intensities higher than 5/10 who did not respond to systemic medication therapy. 4. Patients who can comprehend the study's objectives and adhere to the clinical instructions, return for follow-up, and complete the evaluation questionnaires. 5. Patients able to provide their written informed consent to participate to the study and to use their data anonymously for scientific purposes Exclusion Criteria: 1. presence of active malignancy of any type or history of malignancy 2. Local or systemic infection. 3. Uncooperative patient or suffering from neurological disorders, therefore unable to follow the clinical instructions or unable to provide informed consent for participation in the study or who have not provided written consent. 4. Any case not described in the inclusion criteria. Patients with contraindication to magnetic resonance imaging
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06844552 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06844552 currently recruiting?
Yes, NCT06844552 is actively recruiting participants. Contact the research team at gallelli@unicz.it for enrollment information.
Where is the NCT06844552 trial being conducted?
This trial is being conducted at Catanzaro, Italy, Catanzaro, Italy.
Who is sponsoring the NCT06844552 clinical trial?
NCT06844552 is sponsored by University of Catanzaro. The trial plans to enroll 120 participants.